Skip to content

effectiveness of intratympanic steroid injection for sudden sensorineural hearing loss

effectiveness of intratympanic steroid injection for sudden sensorineural hearing loss - effectiveness of intratympanic steroid injection for sudden sensorineural hearing loss

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000019021
Enrollment
210
Registered
2015-10-01
Start date
2015-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sudden sensorineural hearing loss

Interventions

intratympanic steroid injection

Sponsors

Keio university otorhinolaryngotogy
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1, 2, 3,

Exclusion criteria

Exclusion criteria: 1, 2, 3 4, 5, 6,

Design outcomes

Primary

MeasureTime frame
1,PTA 2 month after the therapy 2,SDS 2 month after the therapy

Secondary

MeasureTime frame
1,PTA 1 month,3 month and 6 month after the therapy 2,vertigo 1 month,2 month,3 month and 6 month after the therapy 3,tympanic menbrane perforaition 1 month,2 month,3 month and 6 month after the therapy

Countries

Japan

Contacts

Public ContactSho Kanzaki

Keio university hospital otorhinolaryngotogy

skan@sc.itc.keio.ac.jp03-3353-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026